The randomized controlled trial has justifiably been embraced as necessary to the delivery of evidence based medicine. In an ideal world every treatment uncertainty would be dealt with in this way. However, as editorialist Neena Modi points out, recent experience in the United States highlights the unexpected barriers to doing this.
↧